Background-Beat-to-beat alternans of cellular repolarization is closely linked to ventricular arrhythmias in humans. We hypothesized that sarcoplasmic reticulum calcium reuptake by SERCA2a plays a central role in the mechanism of cellular alternans and that increasing SERCA2a gene expression will retard the development of cellular alternans.
A lthough ventricular arrhythmias are the most common cause of cardiovascular mortality, the mechanisms responsible for triggering electric instability in the heart are poorly understood. Cardiac alternans is a repetitive beat-tobeat fluctuation of cellular repolarization that is closely associated with ventricular arrhythmias and sudden cardiac death in a wide variety of experimental 23, 36, 43 and clinical 33, 40 conditions. It is clear that alternans arises from alternation of action potential duration (APD-ALT) at the level of the single cell, 12, 17 and it has been proposed that APD-ALT arises secondarily from an effect on calcium-sensitive electrogenic sarcolemmal currents during cytosolic calcium alternans (Ca-ALT) 9, 42, 7, 13 Therefore, understanding the cellular and molecular basis for Ca-ALT can provide important and novel insights into mechanisms of ventricular arrhythmias.
Clinical Perspective on p 694
It is generally accepted that cellular alternans occurs when the heart rate (HR) exceeds capabilities of the cardiac myocyte to cycle calcium on a beat-by-beat basis. This hypothesis predicts that during steady state (ie, resting HR), the amount of Ca 2ϩ released from the sarcoplasmic reticulum (SR) to initiate cardiac contraction must be matched by the Ca 2ϩ reclaimed from the cytoplasm, primarily by SERCA2a. Any sustained disturbance in the myocyte's ability to load or release SR Ca 2ϩ presumably leads to the development of Ca 2ϩ alternans. For example, instabilities of SR Ca 2ϩ release through the RyR release channel either with 7 or without 13, 27 fluctuations of SR Ca 2ϩ content has been argued as a mechanism for cellular alternans. An alternative and equally compelling hypothesis implicates impaired SR reuptake in the mechanism of Ca-ALT. 43 However, the specific SR Ca 2ϩ cycling proteins underlying the molecular basis for cellular alternans are unknown. Recent data from our laboratory provide important insight into the molecular basis for cellular alternans. In particular, cardiac myocytes that are most susceptible to APD-ALT exhibit reduced expression of the SERCA2a and delayed SR Ca 2ϩ reuptake 42, 19 These findings led us to hypoth-esize in the present study that SERCA2a function plays a critical role in the initiation of cellular alternans.
Identification of a molecular basis for cardiac alternans has been challenging because of difficulties in distinguishing experimentally the complex interactions between sarcolemmal and sarcomeric ionic fluxes using relatively nonspecific pharmacological probes. However, gene transfer techniques can be used to alter the expression of single proteins, and, in this way, disease mechanisms can be elucidated and potential therapeutic targets identified. Therefore, to test our hypothesis that SERCA2a function is an important mechanism in the initiation of cellular alternans, we performed in vivo gene transfer of Ad.SERCA2a.GFP in the guinea pig heart. Overexpression of SERCA2a significantly inhibited cellular alternans and susceptibility to ventricular arrhythmias in the intact beating guinea pig heart. These data establish a molecular mechanism for arrhythmogenic cardiac alternans. Specifically, enhancement of SERCA2a gene expression will diminish susceptibility to cellular alternans, thereby interrupting an important pathway to cardiac fibrillation in the intact heart.
Methods

In Vivo Gene Delivery
Recombinant adenoviral vectors were used with cytomegalovirusdriven expression cassettes for SERCA2a (Ad.SERCA2a) with a second cassette in each adenovirus containing GFP substituted for E1 by means of homologous recombination as previously described. 6 Control adenoviral vectors were used with cytomegalovirus-driven expression cassettes for GFP (Ad.GFP) or ␤-galactosidase (Ad.␤-gal).
Experiments were carried out in accordance with the United States Public Health Service guidelines for the care and use of laboratory animals. In vivo gene transfer was performed using a modified cross-clamping method. 4 Briefly, animals were anesthetized (Ketamine, Xylazine, Acepromazine, and Atropine) and mechanically ventilated (2.0-cc tidal volume at 50 cycles per minute) via a tracheostomy (18-gauge tube). An anterior thoracotomy was performed, and the pulmonary artery and aorta were isolated. A 27-gauge catheter was advanced from the apex to the aortic root. Subsequently, the aorta and pulmonary artery were cross-clamped for 50 to 60 seconds, and the virus solution (1ϫ10 12 particle/mL Ad.SERCA2a.GFP, nϭ7; 1ϫ10 12 particle/mL Ad.GFP, nϭ5; or 1.2ϫ10 11 particle/mL Ad.␤-gal, nϭ3; plus 75 g/mL of nitroglycerin) was injected. The animals were placed on a heating pad (42°C), the chest was closed, and intrathoracic air was evacuated. Animals were extubated on spontaneous breathing and closely observed until fully awake.
Efficiency of In Vivo Gene Transfer
Qualitative Assessment of Transduction Efficiency
Seventy-two hours after gene transfer with ␤-galactosidase, animals (nϭ3) were euthanized with pentobarbital. The heart was rapidly removed, flushed with phosphate-buffered saline, and transversely sliced into 3 pieces used for x-gal staining. 8 This procedure was performed to assess the regional distribution and homogeneity of gene delivery in the intact heart.
Quantitative Assessment of Transduction Efficiency
Seventy-two hours after gene transfer, myocytes isolated from the left ventricular free wall were examined by fluorescence microscopy to calculate transduction efficiency. Efficiency is reported as the percentage of all myocytes in the microscope field that fluoresced green.
SERCA2a Protein Expression
Myocytes isolated from the transmural left ventricular free wall of both SERCA2a transduced hearts and age-matched control hearts, as previ-ously described, were used for Western blotting to determine the relative expression levels of SERCA2a. 42 Cardiac homogenates (10 g for SERCA2) were separated on SDS-PAGE and transferred to polyvinylidene diflouride membranes. Blots were probed with rabbit anti-SERCA antibody (Dr Periasamy, Ohio State University). They were then treated with horseradish peroxidase-conjugated anti-rabbit antibody. Protein bands were quantified using ImageQuant software.
Isolated Myocyte Studies
Seventy-two hours after in vivo gene transfer, isolated myocyte electrophysiological studies were performed. Membrane voltage and intracellular calcium were measured simultaneously using the perforated patch technique and the fluorescent Ca 2ϩ indicator indo-1 AM . Myocytes transduced with Ad.SERCA2a and Ad.GFP (ie, control) were confirmed using GFP fluorescence. Because there were no statistical differences in calcium cycling characteristics and alternans susceptibility between myocytes isolated from untreated hearts and Ad.GFP transduced hearts, data are presented as a combined control group.
Patch-Clamp Recordings
The amphotericin perforated patch technique was used to obtain whole-cell recordings of membrane voltage under current-clamp conditions as described previously. 3 Briefly, the cells were bathed in a chamber continuously perfused with Tyrode solution composed of (mmol/L) NaCl 137, KCl 5.4, CaCl 2 2.0, MgSO 4 1.0, glucose 10, HEPES 10, pH to 7.35 with NaOH. Patch pipettes were pulled from borosilicate capillary glass and lightly fire-polished to resistance 0.9 to 1.5 mol/L⍀ when filled with electrode solution composed of (mmol/L) aspartic acid 120, KCl 20, NaCl 10, MgCl 2 2, HEPES 5, and 240 g/mL of amphotericin-B (Sigma, St Louis, Mo), pH7.3. A gigaseal was rapidly formed. Typically, 10 minutes later, amphotericin pores lowered the resistance sufficiently to current-clamp the cells. Myocytes were paced using a 1.5 to 2 diastolic threshold, 5-ms current pulse. Experiments were performed at 30°C. Command and data acquisition were operated with an Axopatch 200B patch-clamp amplifier controlled by a personal computer using a Digidata 1200 acquisition board driven by pCLAMP 7.0 software (Axon Instruments, Foster City, Calif).
Calcium Transient Recordings
Intracellular Ca 2ϩ transients were measured simultaneously using the fluorescent Ca 2ϩ indicator indo-1 AM as described previously. 18 Cells were loaded with indo-1 AM by incubating them in Tyrode containing indo-1 AM (2 mol/L) (Molecular Probes) and 0.025% (wt/wt) Pluronic F-127 (Molecular Probes) for 30 minutes at room temperature. The intracellular indo-1 was excited at 355 nm. Fluorescence emitted at 405 and 485 nm was collected by 2 matched photomultiplier tubes. Data were filtered at 200 Hz and sampled at 1 kHz. The ratio of the intensity of fluorescence emitted at 405 nm over that at 485 nm was calculated after subtraction of background fluorescence as described previously. 16 The emission field was restricted to a single cell with the aid of an adjustable window. To determine intracellular calcium concentration, the ratiometric calcium transients were calibrated using the techniques developed by Grynkeiwicz et al. 10 The calibration parameters, R min and R max , were obtained from isolated myocytes with either a modified calcium-free, R min (nϭ8) or a calcium-saturated, R max (nϭ8) Tyrode solution. The modified R min solution contained (mM) 132 KCl, 1.0 MgCl 2 , 10 EGTA, 10 HEPES, 0. 
Stimulation Protocol
Myocytes were stimulated at a baseline stimulation rate of 150 beats per minute (bpm). After a period of stimulation to establish steady state, measurements were made for the subsequent 20 beats. This protocol was repeated at progressively faster rates until 1:1 capture was lost.
Whole Heart Studies
Whole heart electrophysiological studies were performed in Ad.SERCA2a and control hearts. Because there were no statistical differences in alternans magnitude, alternans HR threshold, and arrhythmia susceptibility between untreated control (nϭ5) and shamoperated Ad.GFP controls (nϭ3), data are presented as a combined control group (nϭ8). Isolated hearts were Langendorff-perfused with oxygenated (95% O 2 , 5% CO 2 ) Tyrode solution (in mmol/L: NaCl 130, NaHCO 3 25.0, MgSO 4 1.2, KCl 4.75, dextrose 5.0, CaCl 2 1.25, pH 7.40, 32°C), and the endocardial surface was eliminated by a cryoablation procedure described previously. 25 This model is highly optimal to study alternans after gene transfer because our current gene delivery technique provides greatest gene transfer to the epicardium ( Figure 1A ).
High-resolution optical action potentials were recorded from the anterior surface of the left ventricle using the voltage sensitive dye di-4-ANEPPS (15 mol/L), as previously described. Cardiac alternans is induced by stepwise decrements (10 ms) in pacing cycle length (CL) but was not measured until 30 seconds after the decrement in rate to ensure its stability. 41 CL was decremented until failure to capture the preparation or the development of a ventricular arrhythmia. 23
Data Analysis
Isolated Myocytes
APD was measured at 90% repolarization (APD 90 ). Ca 2ϩ transient parameters were defined as described previously 19, 42 : Diastolic Ca 2ϩ was defined as cytosolic Ca 2ϩ level just before the onset of the Ca 2ϩ transient or just before the action potential upstroke in the cases in which there was no obvious Ca 2ϩ transient. Amplitude of intracellular Ca 2ϩ transient was calculated from the difference between peak and diastolic Ca 2ϩ . The duration of intracellular Ca 2ϩ transient was measured as the onset of the Ca 2ϩ transient to the point of time when the transient decayed 90% of its amplitude. To further quantify the rate of reuptake of intracellular Ca 2ϩ , the decay portion of the Ca 2ϩ transient (from 30% to 100% of decline phase) was fit to a single exponential function whose time constant, , was used to measure Ca 2ϩ decay.
APD-ALT was measured by calculating the difference in action potential duration (APD 90 ) on 2 consecutive beats and was defined to be present when APD-ALT exceeded 10 ms, as previously described. 26 Ca-ALT was measured by calculating the difference in amplitude on 2 consecutive beats and was defined to be present when Ca-ALT exceeded 10% of Ca 2ϩ transient amplitude, as described previously. 19 
Whole Heart
APD-ALT was defined as the difference in APD between 2 consecutive beats. 29, 25 The alternans-HR relation was plotted as the magnitude of APD-ALT as a function of HR. A leftward or rightward shift in this relation (ie, development of alternans at lower or higher HRs) indicates greater or reduced susceptibility to alternans, respectively. The slowest HR that induces alternans was defined as the threshold HR for alternans. 29, 25, 26 Activation time, repolarization time, and APD were measured from optically recorded action potentials using automated algorithms that have been validated extensively. 25, 26, 32 Dynamic APD restitution was measured by plotting APD as a function of DI measured during periods of rapid pacing used to promote alternans. 29 Arrhythmia susceptibility was determined using a standardized ramp pacing protocol starting at 300 ms (200 bpm) with stepwise 10-ms decrements in pacing CL until failure of 1/1 capture or the induction of a ventricular arrhythmia. 29 Arrhythmias were defined as a tachyarrhythmia sustained for Ͼ30 seconds after pacing was halted.
Statistical Analysis
Statistical analyses of data were performed using Sigmastat (SPSS, Inc, Chicago, Ill). Statistical differences were assessed with Student t test and Fisher exact test as appropriate. When unequal variance was detected during normality testing, the Wilcoxon rank-sum test was used. Results are expressed as meanϮSEM. 
Results
Efficiency of Transgene Expression
Effect of SERCA2a Gene Transfer on Calcium Transient Characteristics
Intracellular Ca 2ϩ transients and action potentials were induced under current clamp-conditions at a pacing rate of 150 bpm at 30°C and were compared between isolated control myocytes and myocytes transduced with Ad.SERCA2.GFP 72 hours after in vivo gene transfer. As shown in Figure 2A , SERCA2a overexpression (right), produced, as expected, accelerated reuptake of cytosolic Ca 2ϩ as measured by the time constant, , of Ca 2ϩ transient recovery. Also, Ca 2ϩ transient amplitude was significantly increased ( Figure 2B ) and diastolic Ca 2ϩ was not statistically different between Ad.SERCA2a and control myocytes. Despite differences in Ca 2ϩ transient characteristics, APD was not significantly changed by SERCA2a overexpression (Figure 2A ). As expected, these data demonstrated that in vivo transduction of Ad.SERCA2a improved SR Ca 2ϩ reuptake accompanied by larger Ca 2ϩ transients and faster rates of [Ca 2ϩ ] i decline, confirming that this model of SERCA2a overexpression produces a meaningful effect on SR calcium cycling.
Effect of SERCA2a Gene Transfer on Susceptibility to Cellular Alternans in Isolated Myocytes
APD-ALT and Ca-ALT were measured simultaneously as stimulus rate was progressively increased. Figure 3A shows representative examples of action potential and Ca 2ϩ transient recordings obtained from an Ad.SERCA2a myocyte and a control myocyte. Traces recorded from 2 consecutive beats are superimposed to illustrate alternans. APD-ALT and Ca-ALT were induced as stimulation rate was increased to 200 bpm in control myocytes. In contrast, alternans could not be initiated even at a pacing rate of 240 bpm in the Ad.SERCA2a myocyte. Data from control myocytes (nϭ9) and Ad.SERCA2a myocytes (nϭ11) are summarized in Figure 3B . As expected, the magnitude of APD-ALT increased in a rate-dependent fashion. However, in contrast to control myocytes, Ad.SERCA2a myocytes exhibited a significant rightward shift if the APD-ALT-HR relationship with greatly attenuated APD-ALT magnitude, indicating induction of marked resistance to APD-ALT with SERCA2a overexpression. The inset of Figure 3B shows that under currentclamp conditions, the threshold stimulation rate for both APD-ALT and Ca-ALT in control myocytes (nϭ9) is significantly lower than in Ad.SERCA2a myocytes (nϭ9). Figure 4 illustrates that SERCA2a overexpression imparts significant resistance to cellular alternans even under constant Figure 4B ) reaffirmed that overexpression of SERCA2a suppressed Ca-ALT as a result of its effects on cellular Ca 2ϩ cycling rather than any indirect effects of the action potential.
Effect of SERCA2a Gene Transfer on Susceptibility to Cellular Alternans in the Intact Beating Heart
APD alternans was measured as pacing rate was progressively increased in the Langendorff-perfused whole heart. Figure 5 demonstrates that overexpression of SERCA2a increased alternans threshold and decreased alternans magnitude in the whole heart. The plot of pacing rate versus magnitude of APD-ALT from summary data of control (nϭ8) and Ad.SERCA2a (nϭ4) transduced hearts shows that the magnitude of APD-ALT increased as pacing rate increased, and the magnitude of APD-ALT was consistently greater in control compared with Ad.SERCA2a hearts. The inset shows that the HR threshold for APD-ALT in control hearts is significantly lower than in Ad.SERCA2a hearts (PϽ0.01). Also, as expected, conduction velocity was not different between Ad.SERCA and control hearts (41.8Ϯ6.4 cm/s versus 32.6Ϯ2.5 cm/s; Pϭ0. 24 ).
In addition to calcium cycling mechanisms, APD restitution has been implicated in the mechanism of APD-ALT. However, as shown in Figure 6 , there was no difference in APD restitution (average APD restitution from all experi- ments are plotted) between control hearts and Ad.SERCA2a hearts. Moreover, derived metrics of restitution properties such as maximum restitution curve slope and predicted onset HR for APD-ALT failed to predict the marked reduction in susceptibility to APD-ALT seen SERCA2a-treated hearts. Figure 7A shows representative optical action potential tracings from control and Ad.SERCA2a transduced hearts. In the control heart, beat-to-beat alternation of APD is seen immediately preceding the onset of ventricular fibrillation. This was a consistent finding in all control preparations. Conversely, in the heart transduced with Ad.SERCA2a, the identical stimulation sequence fails to induce cellular alternans or ventricular fibrillation. Figure 7B demonstrates that SERCA2a overexpression reduced susceptibility to alternans-mediated ventricular arrhythmias compared with control (PϽ0.05).
Effect of SERCA2a Gene Transfer on Susceptibility to Ventricular Arrhythmia
In summary, these data show that overexpression of SERCA2a inhibited cellular alternans in both isolated myocytes and the whole heart, suggesting that SERCA2a function plays an important role in the initiation of cellular alternans. Furthermore, SERCA2a overexpression suppresses alternansmediated ventricular arrhythmias in the intact beating heart.
Discussion
Previously, we 25 and others 30 demonstrated that cellular alternans is a mechanistic precursor to ventricular fibrillation in the mammalian heart. Presumably in diseased hearts, by lowering the HR threshold for T-wave alternans, vulnerability to ventricular fibrillation increases. Therefore, identifying molecular mechanisms that modulate susceptibility to alternans could provide important clues to novel triggers of electric instability in the heart. The primary findings of this investigation are (1) overexpression of SERCA2a significantly inhibited cellular alternans in both isolated myocytes and the whole heart, and (2) SERCA2a overexpression suppresses alternans-mediated ventricular arrhythmias in the intact beating heart. These data support our hypotheses that SR calcium cycling plays a causative role in cellular alternans, SERCA2a function specifically plays an important role in the initiation of cellular alternans, and SERCA2a is a potentially novel molecular therapeutic target for the treatment of ventricular arrhythmias.
Sarcoplasmic Reticulum Ca 2؉ Cycling Underlies Mechanism of Cellular Alternans
There are 2 major hypotheses that have been proposed to explain the development of cellular alternans: (1) the APD restitution hypothesis, largely secondary to alternating sarcolemmal currents, and (2) the calcium cycling hypothesis, which states that alternans occurs when HR exceeds the capacity of the myocyte to cycle calcium. Theoretical models suggest that APD alternans occurs when the slope of the APD restitution curve exceeds unity. Moreover, a variety of sarcolemmal currents such as I to, 21 I Ca , 18 and I Kr 22 can exhibit alternating-type activity. Although the restitution hypothesis provides a very useful theoretical framework for understanding the dynamics of APD alternans, there is also considerable experimental evidence that does not support the restitution Ad.SERCA2a hearts. Inset shows that the actual threshold pacing rate for alternans was lower in control versus Ad.SERCA2a hearts, yet there was no significant difference in maximum APD restitution slope or the predicted alternans thresholds.
hypothesis. 29, 9 By using in vivo gene transfer to selectively increase SERCA2a expression, the present study shows that selective enhancement of SR Ca 2ϩ reuptake significantly inhibits both Ca-ALT and V m -ALT. These findings indicate a causative role of SR Ca 2ϩ cycling in the mechanism of V m -ALT. However, it is also possible, based on theoretical predictions, that SERCA2a overexpression could have altered sarcolemmal ionic currents and that these alterations could alter susceptibility to cellular alternans. 39 In the present investigation, we distinguished mechanisms arising from intracellular Ca 2ϩ handing versus sarcolemmal ionic currents in isolated myocytes by using a nonalternating action potential (AP) clamp. Moreover, because AP clamp is not possible in the intact heart, we compared APD restitution properties of SERCA2a with controls, particularly because APD restitution has been used as an index of the extent to which sarcolemmal ionic currents drive cellular alternans. Interestingly, suppression of Ca-ALT under AP clamp conditions in myocytes (Figure 4 ) and the lack of a change in APD restitution in whole hearts overexpressing SERCA2a ( Figure 6 ) provide important new evidence that calcium cycling properties can underlie susceptibility to alternans without any involvement of APD restitution. Also, our data are consistent with previous observations that inhibiting Ca 2ϩ cycling by blocking the RyR, I Ca or by depleting SR Ca 2ϩ stores with caffeine eradicates V m -ALT. 11, 34, 35 Furthermore, the seminal observations of Chudin et al 3 and our laboratory 42 that Ca-ALT is similarly induced under current-clamp (where V m -ALT occurs) and voltageclamp (ie, where V m -ALT is prevented) conditions proved that Ca-ALT is not dependent on V m -ALT and strongly supported the notion that cellular alternans arises from SR Ca 2ϩ cycling.
Role of SERCA2a in Molecular Mechanism of Cellular Alternans
Despite the importance of Ca-ALT on the development of APD-ALT, the specific Ca 2ϩ cycling proteins responsible for alternans were based primarily on predictions from theoretical models and experimental evidence relying on associations between impaired SR calcium handling, diminished expression of calcium handling proteins, and susceptibility to cellular alternans. 42, 43, 19 The advantage to using in vivo gene transfer targeting a single gene, as in the present study, is the ability to demonstrate a causal relationship between a single protein and the development of cellular alternans. Previously, we suggested that impaired SR Ca 2ϩ reuptake may represent a mechanism to initiate alternans. 42 For example, when compared with epicardial myocytes, endocardial myocytes had reduced SERCA2a expression and reduced ability to reuptake cytosolic Ca 2ϩ into the SR. As such, we hypothesized that reduced SERCA2a expression may underlie the increased susceptibility of endocardial myocytes to develop cellular alternans. In the current investigation, we performed in vivo gene transfer using a modified aorto-pulmonary artery cross-clamp technique to achieve a 37% increase in SERCA2a. This resulted in improved SR Ca 2ϩ reuptake (ie, accelerated Ca 2ϩ transient decay and increased Ca 2ϩ transient amplitude) and inhibited cellular alternans in both isolated myocytes and the whole heart. Our results are consistent with the recent observations of Xie et al 44 that adenoviral-mediated SERCA2a overexpression in cultured rabbit ventricular myocytes suppresses Ca-ALT and the findings that the SERCA2a inhibitor thapsigargin increases susceptibility to cellular alternans. 15 Though this investigation demonstrates with a high degree of specificity that the SERCA2a protein directly affects susceptibility to cellular alternans, these data do not rule out other synergistic or complementary molecular mechanisms. For example, observations from both experimental and theoretical models have demonstrated a steep dependence of SR Ca 2ϩ release on SR Ca 2ϩ load as a mechanism for the development of Ca 2ϩ alternans. 7, 43 Diaz et al 7 used an innovative albeit nonphysiological stimulation protocol to induce Ca-ALT without pharmacological inhibition of RyR (thereby avoiding nonselective drug effects). Ventricular myocytes were repetitively voltage-clamped below the activation voltage for I Ca . The resulting weak CICR produced desynchronized RyR release, which dramatically steepened the relationship (feedback gain) between SR Ca 2ϩ content (ie, luminal Ca 2ϩ ) and the subsequent SR Ca 2ϩ release. These subcellular conditions highly favored the development of Ca-ALT dynamics that are dependent on beat-to-beat alternation of SR Ca 2ϩ content. Moreover, instabilities of SR Ca 2ϩ release can also lead to Ca-ALT. For example, using metabolic inhibition in cat atrial and ventricular myocytes to inhibit RyR phosphorylation, Huser et al 13 Interestingly, in the present study, inhibition of cellular alternans in the intact heart occurred despite modest adenoviral transduction efficiency on a cellular scale (29Ϯ2% of myocytes). Importantly, our method of virus delivery produced spatially homogeneous transgene expression in essentially all regions of the heart that were readily accessible for detailed electrophysiological phenotyping using highresolution optical mapping of the intact heart. Moreover, this study demonstrates that complete gene transfer is not required to produce an important electrophysiological phenotype. One explanation for this finding is that electrotonic interactions between neighboring cells via gap junctions act to homogenize membrane potential across cells. For example, reduction in Ca-ALT and therefore APD-ALT in a cell transduced with Ad.SERCA2a is expected to attenuate APD-ALT in a nontransduced neighboring cell. This is supported by the observation that the magnitude of SERCA2a suppression of cellular alternans in isolated myocytes ( Figure 3B ) is greater than in whole hearts ( Figure 5 ). These findings have practical clinical implications, suggesting that strategies designed to target SERCA2a gene expression in patients probably does not need to achieve high transduction efficiency for a desirable clinical benefit to be realized. However, it is likely that gene delivery does need to be spatially homogenous throughout the myocardium because lack of homogeneity could produce electrophysiological heterogeneities that are potentially arrhythmogenic. In fact, the completion of a phase 1/2 clinical trial of Myocardial Delivery of AAV1/SERCA2a in Subjects with Advanced Heart Failure has been shown to have an acceptable safety profile in the patients. 37
Enhanced SERCA2a Gene Expression Interrupts a Pathway to Arrhythmogenesis
The present study demonstrates that targeted overexpression of SERCA2a reduces cellular alternans and susceptibility to inducible arrhythmias in the intact heart. Previously, we demonstrated a mechanistic link between cellular alternans and the genesis of ventricular arrhythmias. 25 Specifically, discordant alternans (ie, repolarization alternans occurring with opposite phase between neighboring cells) alters the spatial organization of repolarization across the ventricle by markedly amplifying preexisting heterogeneities of repolarization in the heart, producing a substrate prone to conduction block and reentrant arrhythmogenesis. Therefore, suppression of cellular alternans in the present study decreases the likelihood for amplifying heterogeneity of repolarization, conduction block, and thus, ventricular arrhythmias. This observation is consistent with the clinical observation that patients with heart failure with a negative T-wave alternans test (the surface ECG representation of cellular alternans) are remarkably resistant to sudden cardiac death. 38 Furthermore, our data are supported by the observations of del Monte et al 6 and Prunier et al 28 that overexpression of SERCA2a suppressed ventricular arrhythmias in both rat and porcine models of ischemia-reperfusion (Ca 2ϩ overload). Specifically, ischemiareperfusion increases diastolic calcium and has been linked to delayed afterdepolarizations and triggered arrhythmias. The authors speculate that enhanced SR calcium reuptake with SERCA2a overexpression decreases diastolic Ca 2ϩ , thus decreasing the incidence of delayed afterdepolarizations and triggered arrhythmias. Additionally, Prunier et al 28 speculated that a possible mechanism by which SERCA2a overexpression suppressed the development of ventricular arrhythmias in ischemiareperfusion is by inhibiting cellular alternans.
Targeted overexpression of SERCA2a as an antiarrhythmic therapy has a potential advantage in that this approach does not target sarcolemmal K ϩ channels; a strategy known to cause QT interval prolongation and proarrhythmia. SERCA2a gene transfer did not prolong repolarization in our studies. However, it is possible that overexpression of SERCA2a could be arrhythmogenic because enhanced SR calcium load could increase susceptibility to spontaneous SR calcium release and delayed afterdepolarization-mediated triggered arrhythmias. However, in the present study we saw no evidence of spontaneous arrhythmias or delayed afterdepolarizations. This may be explained by the modest degree of SERCA2a overexpression seen in this study.
Pathophysiological Implications
Our data have important clinical implications. T-wave alternans has been observed in patients with heart failure and is an important marker of risk for sudden cardiac death. 24, 31, 38 Moreover, altered calcium cycling is a common observation in heart failure 1 probably caused by reduced SERCA2a expression (impaired SR Ca 2ϩ reuptake), increased phosphorylation of RyR (impaired SR Ca 2ϩ release), and/or altered NCX expression/function. The current investigation suggests that SERCA2a dysfunction can play an important role in modulating susceptibility to cellular alternans, providing a potential link between mechanical and electric dysfunction in the failing heart. To our knowledge, our data are the first to support a direct causal relationship between SERCA2a function and susceptibility to cellular alternans in the intact heart. Importantly, SERCA2a overexpression has been shown to reverse failure-induced changes in contractility. 5 Moreover, inhibition of cellular alternans produces a myocardial substrate that is resistant to reentry and fatal arrhythmias. As such, in vivo gene transfer targeting key SR Ca 2ϩ cycling proteins (ie, SERCA2a) provides a novel method for understanding the underlying mechanisms for the development of sudden cardiac death. More importantly, an understanding of these mechanisms combined with improved gene transfer techniques offer a novel strategy for arrhythmia therapy in humans.
